Content
Lessons
Feedback
Overview

1- Monday Infectious Disease News – 25th October

 


1 – A study of COVID vaccine boosters suggests Moderna or Pfizer works best

  • If you got the Johnson & Johnson vaccine as your first COVID-19 shot, a booster dose of either the Moderna or Pfizer-BioNTech vaccine apparently could produce a stronger immune response than a second dose of J&J’s vaccine. That’s the finding of a highly anticipated study released Wednesday.
  • And if you started out with either Pfizer or Moderna, it probably doesn’t matter that much, the research suggests, as long as you get one of the two mRNA vaccines as a booster.
  • The study, which was sponsored by the National Institutes of Health, involved 458 volunteers.
  • They were divided into nine groups with roughly 50 volunteers in each group.
  • Those who initially got the two-dose Moderna or Pfizer vaccines got either a Moderna shot, a Pfizer shot or a Johnson & Johnson shot as a booster four to six months after their primary immunization.
  • And people who got the one-shot J&J vaccine either got another J&J shot or a Moderna or Pfizer booster.
  • The researchers then measured antibody levels in all of those people two weeks and four weeks after the boost.

Source: NPR


2 – Vertical Transmission of Gut Microbiome and Antimicrobial Resistance Genes in Infants Exposed to Antibiotics at Birth

  • Vertical transmission of maternal microbes is a major route for establishing the gut microbiome in newborns.
  • The impact of perinatal antibiotics on vertical transmission of microbes and antimicrobial resistance is not well understood.
  • Using a metagenomic approach, we analyzed the fecal samples from mothers and vaginally delivered infants from a control group (10 pairs) and a treatment group (10 pairs) receiving perinatal antibiotics.
  • Antibiotic-usage had a significant impact on the main source of inoculum in the gut microbiome of newborns.
  • In conclusion, perinatal antibiotics markedly disturbed vertical transmission and changed the source of gut colonization towards horizontal transfer from the environment to the infants.

Source: Oxford Academic


3 – Multifunctional Antibodies Are Induced by the RTS,S Malaria Vaccine and Associated With Protection in a Phase 1/2a Trial

  • RTS,S is the leading malaria vaccine candidate but only confers partial efficacy against malaria in children.
  • RTS,S is based on the major Plasmodium falciparum sporozoite surface antigen, circumsporozoite protein (CSP).
  • The induction of anti-CSP antibodies is important for protection; however, it is unclear how these protective antibodies function.
  • This data suggest a role for Fc-dependent antibody effector functions in RTS,S-induced immunity.
  • Enhancing the induction of these functional activities may be a strategy to improve the protective efficacy of RTS,S or other malaria vaccines.

Source: Oxford Academic


4- Limited Neutralization of Authentic Severe Acute Respiratory Syndrome Coronavirus 2 Variants Carrying E484K In Vitro

  • Whether monoclonal antibodies are able to neutralize severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern has been investigated using pseudoviruses.
  • In this study they show that bamlanivimab, casirivimab, and imdevimab efficiently neutralize authentic SARS-CoV-2, including variant B.1.1.7 (alpha), but variants B.1.351 (beta) and P.2 (zeta) were resistant against bamlanivimab and partially resistant to casirivimab.
  • Whether antibodies are able to neutralize severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variantshas been investigated using pseudoviruses.
  • They show that authentic SARS-CoV-2 carrying E484K were resistant against bamlanivimab and less susceptible to casirivimab, convalescent and vaccine-elicited sera.

Source: Oxford Academic


5 – Antibiotic prescription policy for acute otitis media: do we follow the guidelines?

  • Acute otitis media (AOM) is a common cause for antibiotic prescription.
  • Most guidelines endorse abstaining from immediate antibiotic treatment (‘watchful waiting’, WW) in mild–moderate episodes.
  • In this study they studied adherence rates to the latest AOM guidelines (2013), in terms of antibiotic type and prescription options.
  • Improved adherence to the 2013 guidelines was observed only in children aged ≤6 months and over-treatment with antibiotics was still high.

Source: Oxford Academic


6 – Bactericidal activities and post-antibiotic effects of ofloxacin and ceftriaxone against drug-resistant Salmonella enterica serovar Typhi

  • The clinical response to ceftriaxone in patients with typhoid fever is significantly slower than with ofloxacin, despite infection with Salmonella enterica serovar Typhi (S. Typhi) isolates with similar susceptibilities (MIC 0.03–0.12 mg/L).
  • The response to ofloxacin is slower if the isolate has intermediate susceptibility (MIC 0.25–1.0 mg/L).
  • This study aims to determine the bactericidal activity and post-antibiotic effect (PAE) of ceftriaxone and ofloxacin against S. Typhi.
  • Infections with S. Typhi with intermediate ofloxacin susceptibility may respond to doses that maintain ofloxacin concentrations at 4×MIC at the site of infection.
  • The slow bactericidal activity of ceftriaxone and absent PAE may explain the slow clinical response in typhoid.

Source: Oxford Academic



Course Copyrights:

All Courses is meant for SINGLE user use only.
If more than one person acceced this course, they will be BLOCKED Forever.

FeedBack

FADIC 2021 Antimicrobial Resistance FNN News

Directed By/ Rasha Abdelsalam


FADIC Pharmacy’s Daily Newspaper works like this:

  • Each business morning, you receive an email message with the text of that day’s FNN.
  • The message has a link to a PDF file that can be viewed or printed format.
  • Issues for the past reports.

Each and every business day, things change!!

  • More articles are published
  • New drugs are approved
  • Research is presented at medical meetings, policy decisions affecting practice are debated and confirmed.

By subscribing to the FADIC 2020 Pharmacotherapy Daily News (FNN), a daily publication of the Daily News Network “FNN” will be sent to your Email.


📑 Sample of Every Day News 📥

📑 Sample of Monthly Newsletter 📥


You can keep up with what’s important

  • You need not to be disturbed with many newsletters crowding your email inbox about everything.
  • FADIC FNN’s provides you with each business day with a morning email summary of developments in all the areas critical to your clinical practice

FADIC 2021 Antimicrobial Resistance E-News (FNN) Daily Emails Contain:

  • Just-published articles in the biomedical literature
  • Emphasis on the FOUR weekly major important medical journals such as “Lancet, BMJ, JAMA, and NEJM”
  • In addition to the two internal medicine journals as“Annals and JAMA Internal Medicine”
  • Finally, the leading journals in medical speciality areas such as: “IDSA, JACCP, Annals of Pharmacotherapy, and others”.
  • News briefs covering newly approved drugs, warnings and recalls announced by FDA, Saudi FDA, research at medical meetings.
  • Lastly, other important news from International Organizations such as “CDC, WHO, and others”.
FNN Daily News Provide News and Information about Medications and their Proper Use

Why FADIC 2021 Antimicrobial Resistance E-News (FNN) Daily Emails?

  • It helps to keep up with the literature!
  • Provide you with the Updated with the latest in your clinical practice. Wherever you are, and Whenever you need!
  • Help you to share in the advance in clinical career. In addition to adding an impressive image to the pharmacists all-around!


Subscribe to FADIC 2020 Antimicrobial Resistance E-News (FNN), for daily publication of Daily News

Read & Download FNN Issue 8 of April 2020 FNN News






With FADIC 2020 Antimicrobial Resistance E-News (FNN), you Will …





Receive email notification everyday morning

As we all know, the world of clinical research is changing constantly. All medical news, clinical guidelines, and updates become available in your daily medical news issue.


You can read & download news every day

You can access your daily medical everyday morning, once you receive the email notification in the morning, and entre the website, and download your news issue.


You can print your daily news for work

You will receive your FNN daily medical news from international journals, and you can print it and share the latest journal club in your


The full-Text source will be available for you

If you need to know any further details or full-teat for any news, you can open the corresponding links that support you with further details.


You’ll Also Get These Awesome Bonuses…

Bonus #1. Download monthly FNN international issues (Value 300$)

As well as the daily news, there will be a monthly issue with the most important news all over the month, that will help you to stay updated, you can download it and print.


Bonus #2. Your FNN website account support (200$ Value)

You will have your own account in FNN Medical news, in FADIC website, that enables you to follow up on all the previous or missed issues, and read them to catch up on any missed news and download all of them.


Subscribe NOW in FNN – Special Offers for Group and Organisational Subscription


Course Copyrights:

All Courses is meant for SINGLE user use only.
If more than one person acceced this course, they will be BLOCKED Forever.